Project archive

As part of its “one substance, one assessment” approach, the European Commission is planning a centralized, structured database for health-based limit values (HBLVs).

Primary and secondary tumors of the central nervous system (CNS) continue to be associated with an unfavorable prognosis. The aims of this project are, firstly, to define pre-analytical standards for biomarker studies with CSF and, secondly, to develop molecular genetic tests based on panel sequencing, i.e. sequencing of a set of clinically relevant genes.

"PrivacyUmbrella" is a research project of the German Federal Ministry of Education and Research (BMBF). In order to account for the particular privacy concerns relating to personal medical data, the objective of this project is to develop highly specialized anonymization solutions based on modern data analysis.

The International Consortium for Anti-Infective Research iCAIR® has set itself the objective of closing the gap between the discovery of new active substances and developing them into usable therapeutics.

Researchers at Fraunhofer ITEM and the Hannover Medical School MHH have jointly pursued an innovative approach: Together, they have developed an RNA-based active substance to treat human parainfluenza virus (HPIV3) and have also tested it successfully in a preclinical setting.

Fraunhofer researchers are developing solutions to ensure the quality and durability of neural implants while accelerating their development and market entry.

Lung cancer is the most common cause of cancer-related deaths worldwide. A study investigated disseminated cancer cells (DCCs) from lymph nodes of lung cancer patients and their association with later metastases.

Researchers at the Fraunhofer ITEM site in Regensburg played a vital role in designing and executing a complex biomarker study as part of the Omics/Genomics/Liquid Biopsy lighthouse project by the Bavarian Cancer Research Center (BZKF).

Fraunhofer researchers have been investigating a spray product for room conditioning in hairdressing salons. They have carried out in-vitro inhalation experiments to investigate acute effects on the respiratory tract with a battery of tests using cells from human lungs and the P.R.I.T.® ExpoCube® exposure system.

The aim of the MyCellFight project is to develop a fully automated immune chip able to predict the specific immune responses of individuals.